PCV94 THE COST-EFFECTIVENESS OF TITRATION TO GOAL WITH BRAND ROSUVASTATIN COMPARED TO GENERIC SIMVASTATIN IN PATIENTS WITH ELEVATED LOW-DENSITY LIPOPROTEIN CHOLESTEROL: PRIMARY AND SECONDARY PREVENTION IN THE BELGIAN HEALTH CARE SETTING

Volltext
Verfasser: Van den Steen, D
Petit, C
Lamotte, M
Dokumenttyp: Artikel
Erscheinungsdatum: 2009
Reihe/Periodikum: Value in Health ; volume 12, issue 7, page 330 ; ISSN 1098-3015
Verlag/Hrsg.: Elsevier BV
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-28885532
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://dx.doi.org/10.1016/s1098-3015(10)74621-0